A search was made in LCM virus-immune mice for virus-specific antibodies. With the help of an L-cell plaque assay, neutralizing antibody was readily detected. There were no essential differences between mouse strains, but marked differences existed between virus strains. Whereas the inoculation of either large or small doses of WE strain virus led to the early production of considerable concentrations of neutralizing antibody, in the case of E-35o strain virus, high doses were required and a much longer time interval had to elapse before the threshold of detection was attained. In addition to neutralizing antibody, LCM virus-infected mice produced sensitizing antibody (detected by the enhancing effect of an anti-mouse lg antiserum on the ability of a serum to reduce virus infectivity) and complement-fixing antibody. Previous failures to detect neutralizing antibody in LCM virus-immune mice might have been caused by properties of the chosen virus, but in many instances lack of a suitable assay host is a more likely explanation.
INTRODUCTION
The lymphocytic choriomeningitis (LCM) virus-infected mouse is regarded by many as an exceptionally useful model for studying the interaction between a virus and its host. In particular, it is the virus-specific immune response which has attracted much attention. By simply changing a few easily controlled experimental parameters, such as age of the mouse and route of inoculation, infection with a given dose of a given virus strain may lead to such diverse phenomena as immunological tolerance, actively acquired immunological protection and immunopathological disease (reviewed by Lehmann-Grube, I971).
A great deal of work has been, and is being, directed at understanding the complex mechanisms underlying these phenomena. Yet questions concerning other immune responses of the mouse to the LCM virus have not been adequately answered, including that of whether mice are capable of developing virus-neutralizing antibody if infected with LCM virus after weaning. Whereas Hotchin and his colleagues concluded from their observations that such antibody is made irregularly, attains low titres, and appears many months after infection (Hotchin et al. 1969) , found the pattern of LCM virusneutralizing antibody not principally different from the one known from murine infections with other viruses. Employing a plaque reduction assay, we have taken up this issue anew. The data to be reported show that mice respond to the infection with LCM virus with neutralizing and sensitizing in addition to complement-fixing antibodies, but that there are marked quantitative differences between virus strains.
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METHODS
Mice. Female mice, 6 to Io weeks old, were used throughout. CBA/J (CBA) mice were purchased from Jackson Laboratory, Bar Harbor, Maine, U.S.A., and colony-bred NMRI (NMRI) and C57BL/6 (B6) mice from the Zentralinstitut fiJr Versuchstiere, Hanhover, Federal Republic of Germany. NMRI inbred mice, originally provided by Dr D. Lovell, MRC Laboratory Animals Centre, Carshalton, Surrey, Great Britain, were maintained in this institute by continual brother-sister mating. Skin grafts between individual mice were always permanently accepted. (CBA/J × NMRI inbred)F I hybrids were produced by us. Grey house mice came from our own colony, which had been established two years ago with wild mice (Mus musculus) trapped in various parts of Northern Germany.
Mice were bled from the retrobulbar venous plexus at intervals after infection. The blood was left for 2 h at room temperature and overnight at 4 °C, after which the serum was separated and stored in aliquots at -2o °C.
Celt cultures. NCTC clone 929 L cells were cultivated with Eagle's minimum essential medium (MEM) plus non-essential amino acids (Lockart & Eagle, ~959) , supplemented with heat-inactivated calf serum and antibiotics. For certain purposes (see below) horse serum was employed. Incubation was always at 37 °C and the concentration of NaHCOz depended on the culture conditions; in an incubator flushed with 5 % CO2 in air it was o'I4 %.
Virus and virus assay. Most experiments were done with the WE strain of LCM virus (Rivers & Scott, ~936) which was propagated in L cells and stored in aliquots at -7o °C. To avoid possible interference with the plaque reduction assay (which uses calf serum and virus propagated with calf serum) by antibodies against the constituents of calf serum, the virus to be used to infect mice whose serum was to be tested for neutralizing antibody was passaged once and propagated with medium containing horse serum instead of calf serum. Mice were infected with io 2, ro 4 or Io 7 IDa0 of virus and the IDs0 was determined in ordinary NMRI mice as previously described (Lehmann-Grube, I964).
Strain E-35o ('Armstrong') of LCM virus was handled essentially in the same manner.
Determination of neutralizing antibody. LCM virus-neutralizing antibody in mouse sera was titrated as follows. Diluent for virus and sera was Hanks' balanced salt solution minus CaCI2 and MgSO~ but containing twice the concentration of phosphate buffer plus o.oI Mtris (hydroxymethyl) amino methane, 2 % heated calf serum, and antibiotics; the pH was adjusted to 7"4-Virus was diluted to 2oo0 p.f.u./ml and serum was diluted in twofold steps. Mixtures of equal volumes were held for 9o min at 37 °C in a water bath, after which residual infectious virus was determined by plaque assay as previously described (Lehmann-Grube & Ambrassat, t977). The neutralizing antibody titre is defined as the reciprocal of the serum dilution which reduces the plaque number to 50 % of that of a control run in parallel, and is calculated by linear interpolation of the log10 values of the bracketing dilutions. The additional dilution of the serum caused by adding virus is taken into account.
Determination of sensitizing antibody. In principle, sensitizing antibody was determined in the same way as neutralizing antibody except that virus was diluted to contain 30oo p.f.u./ ml and after incubation of the virus-serum mixture another volume (I/3 of the total) of a suitably diluted anti-mouse immunoglobulin (Ig) antiserum was added, followed by further incubation for 30 rain before assaying for residual infectious virus. Anti-mouse Ig antiserum was prepared in rabbits by immunization with purified mouse Ig (Miles GmbH, Frankfurt/ Main, Federal Republic of Germany) and the dilution effecting maximal plaque reduction was determined experimentally. The titre of sensitizing antibody is defined as the reciprocal of the serum dilution (inclusive of the dilution caused by adding the virus but exclusive of the dilution caused by adding the anti-Ig antiserum) which reduces the plaque number to 50 % of that of a control and is calculated by interpolation. 
Determ&ation of compleme.'-fixing (CF) antibody.
Our micro-method for titrating CF antibody has been described (Gschwender et al. I976) . The CF titre of a serum was taken as the reciprocal of the highest dilution which, with antigen in excess, reduced lysis of one unit of sensitized SRBC by two units of complement to approx. 5o %. In calculating the dilution, the twofold step caused by the addition of antigen was taken into account.
RESULTS

LCM virus-specific neutralizing antibody
When tested at low dilutions, all sera from uninfected CBA, B6 and NMRI mice contained virus-inactivating substances of unknown nature which were only slightly affected by heating for 30 min at 56 °C. The concentration of this material, however, was always low and neither native nor inactivated sera significantly reduced plaque numbers when diluted I : 2o. Hence a titre of 2o was the threshold of detection with the type of assay employed here.
An important question was whether inactivation of sera would reduce their neutralizing potential, as has been found to be the case with human sera titrated by means of mouse assays (Ackermann et al. I962 ; I978) . Surprisingly, antibody titres were increased, rather than decreased, by heating the sera, a phenomenon seen in several experiments, one of which is detailed in Table i .
In the sera of CBA, B6 and NMRI mice, neutralizing antibody became detectable 2 to 3 weeks after infection (Fig. t to 3) . It climbed to a plateau where it remained until challenged on day 98, which led to further increases. Later the titres declined somewhat, but even after approx. I year, neutralizing antibody was readily detectable. Only minor differences were observed between the three mouse strains, but there were marked differences between sera from mice infected with Io 2 or lO 7 IDs0. With the high virus dose, antibody appeared earlier, climbed faster and reached much higher concentrations; even challenge with l o 7 IDs0 did not completely obliterate the dissimilarities.
In a further experiment, additional mouse strains were used and the dose of virus and route of inoculation were changed. After intraperitoneal infection with IO 4 IDs0 of strain WE LCM virus, NMRI and CBA, as well as NMRI inbred, (NMRI inbred x CBA)F1 and house mice, responded with neutralizing antibody (data not shown).
The experimental results so far reported were obtained with pooled sera. In order to discover more about the variation between animals, a total of 32 sera from different CBA mice obtained I I weeks after the intravenous infection with either Io S or lo ~ IDso were tested. Mean and single standard deviation of the log a0 titre values of I6 sera from I6 mice 
LCM virus-specific sensitizing antibody
Addition to the virus-mouse antiserum mixture of an antibody directed against mouse Ig enhanced the reduction of infectivity. As illustrated by the results of the experiment detailed in Table 2 , this effect was more marked with sera from mice infected with Io 7 IDs0 than with sera from mice infected with Io ~ IDs0, and it occurred to the same degree with native and inactivated immune sera (data not shown). Enhancement by anti-Ig antiserum was not observed with sera from uninfected mice. Also, none of the sera taken from CBA, B6 and NMRI mice at a time when neutralizing antibody had not yet appeared (see Fig.  I to 3) effected reduction of infectivity when tested in combination with anti-mouse Ig antiserum.
LCM virus-specific CF antibody
CF antibody became detectable before neutralizing antibody (Fig. I to 3 ) and in the case of B6 mice it was maximal z weeks p.i. when we first bled these mice. The earlier appearance and the higher titres of CF antibody after infection with Io 7 IDs0 as compared with infection with IO 2 IDs0 has also been seen in other experiments and, furthermore, is also characteristic of neutralizing antibody. There can be no doubt that the difference of the antibody response of mice to high and low infectious doses is real.
Antibody response of mice to LCM virus, strain E-35o
The experiments reported so far were all done with LCM virus, strain WE. We wanted to know whether the marked biological differences between LCM virus strains would also I" Sera from 15 to 26 mice were pooled. io 2 N CF N CF < I'3Ot < i.i < 1.3o 0.8 < t.3o 2.1o < 1.3o 1.2o < I'3O 2"25 < I'3o 1'35 < 1"3o 2.55 < 1"3o 1"35 < 1"3o 2"55 < 1"3o I"35 < I-3O 2"55 < 1-3o I"35 < I'3O 2'55 < 1-3o 1"35 ~-8o 2"55 < I'3O 1"35 I I"53 2"55 < I'30 2"55 3 I"62 2"55 I'58 2'55 5 I'77 2"55 < I"30 2'25 11 I'72 2"55 < I'30 2"25 * Mice were infected by i.v. inoculation with either lO 7 or IO ~ IDso of virus. Groups of 9 to 15 animals were bled at indicated intervals, their sera were pooled, and neutralizing (N) and complement-fixing (CF) antibodies were determined.
t Titres expressed as log10 values. :~ Challenge by i.v. inoculation of Io ~ IDa0 of virus, 14 weeks after primary infection.
be apparent with respect to the antibody response they elicited in mice. Strain E-350 ('Armstrong') was selected because in many properties this virus is the opposite to WE (Lehmann-Grube, I97 I). The results with CBA mice are laid down in Table 3 . Neutralizing antibody was not detectable 14 weeks p.i. with lo 2 IDs0 and, in the case of I07 IDso, low levels were attained between IO and 14 weeks p.i. Challenge with IO 7 IDs0 did not result in anamnestic responses. All titrations of neutralizing antibody were repeated using E-350 as assay virus, with essentially the same results. In contrast to neutralizing antibody, CF antibody developed rapidly and reached titres comparable with the ones seen after infection with the WE strain virus. When NMRI mice were infected with high and low doses of IP: 54.70.40.11
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strain E-35o virus, somewhat more neutralizing antibody was produced but the overall pattern of the serological response was similar (data not shown).
DISCUSSION
The most noteworthy finding of this investigation is the ability of the adult mouse to respond to infection with LCM virus with the development of neutralizing antibody. Previous attempts to detect this antibody in immune mice had led to equivocal results and positive and negative reports more ar less counterbalanced each other (reviewed by LehmannGrube, 1971) . That mice are capable of making LCM virus-neutralizing antibody was first convincingly shown by Volkert & Hannover Larsen (1965) , who observed the development of high concentrations of neutralizing antibody in LCM virus carrier mice adoptively immunized with lymphoid cells from immune syngeneic donors; but this is a very special case. Hotchin et al (1969) , using the footpad of the mouse for assaying residual infectious virus, detected neutralizing antibody at low concentrations many months after infection with the UBC (= WE) strain of virus. In contrast, , who employed a quantal assay based on the release of CF antigen from L cells, found this antibody in mice as early as 22 days after infection with WE strain virus; this was confirmed here using an entirely different procedure. The mouse strains employed in this study were chosen because of the great differences they exhibit with regard to LCM virus-specific cell-mediated immune responses (F. Lehmann-Grube & J. L6hler, unpublished data). Such differences are not reflected in the antibody responses which were found to be rather uniform. There were, however, marked dissimilarities between virus strains. Whereas neutralizing antibody appeared quickly after infection with either lo 7 or x o 2 IDs0 of strain WE virus, in the case of E-35o, a high dose and a greater interval were required before the threshold of detection was reached. Possibly some of the previous failures to demonstrate neutralizing antibody in LCM virus-immune mice resulted from employing virus strains similar to E-35o. However, in other cases the blame more probably lies with the procedure used. For instance, one of us (F. L.-G.) has previously searched unsuccessfully many times for neutralizing antibody in WE strain virus-infected NMRI mice by using mice as assay hosts.
Our finding that treatment at 56 °C enhances the neutralizing capacity of mouse immune sera remains unexplained. A similar effect had been noted by Traub (196I) . This phenomenon is the more surprising as it has been repeatedly shown that neutralizing antibody in human serum is adversely affected by heat (Ackermann et al. 1962; Lehmann-Grube, 1978) .
We do not know why L cell cultures are so much better suited to detecting LCM virus neutralizing antibody than other hosts, but if one looks at virus neutralization as a ternary system in which antibody and cell compete for the virus (Fazekas de St Groth, 1962) , one explanation is that the avidity of L ceils for the agent is lower than the avidity of the target cells in, for instance, the mouse.
The question of what function neutralizing antibody in the mouse may have remains unanswered. The present finding, that mice develop high concentrations of neutralizing antibody after infection with WE strain virus but little or none (i.e. below the threshold of detection) after infection with E-35o strain virus, although they are solidly immune when challenged by intracerebral inoculation of the virus, supports the accumulated evidence (reviewed by Lehmann-Grube, I97I) that antibodies do not play a crucial role in the immune protection of mice to LCM virus.
In order to allow comparative evaluation, CF antibody and sensitizing antibody were also determined, although observations of their presence are not novel. Since its first description by Traub & Sch~ifer (I939) the appearance of LCM virus-specific CF antibody in immune mice has never been disputed and the observation that the mouse produces LCM virussensitizing antibody confirms previous findings of Otdstone & Dixon (I971) and Theofilopoulos et aL (I974), who detected -by different methods -antibody capable of binding to the virus but not neutralizing it, in adult mice as early as 4 to 5 days p.i.
The higher concentrations of antibodies in mice after infection with high virus doses compared with those after infection with low virus doses -also observed for CF antibody by Hotchin (1969) -contrasts markedly with parameters of cell-mediated immunity which are lower after infection with high rather than low virus doses (Dunlop & Blanden, 1977; Cihak & Lehmann-Grube, 1978) . A detailed analysis of this reciprocal pattern of immune reactivity in LCM virus-infected mice is now being conducted.
